ADGRL1 and attention deficit-hyperactivity disorder: Intriguingly, patients carrying pathogenic variants of Lphn1 display behavioral abnormalities including attention-deficit/hyperactivity disorder, autism spectrum disorder, and epilepsy (Vitobello et al., 2022).